SCHEMBL6173181

SCHEMBL6173181

CC1(Cc2ccnc(OCc3ccccc3)c2)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 5/20 0.43
AR P10275 4/20 0.37
PTPRZ1 P23471 1/20 0.36
ITGAL P20701 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.33
KMT2A Q03164 2/20 0.32
RAB9A P51151 2/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
PGR P06401 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
ALOX12 P18054 1/20 0.32
NFKB1 P19838 1/20 0.32
CYP2C19 P33261 1/20 0.32
PDE4D Q08499 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6177892 0.90 IGF1R (0.43) IGF1RARPTPRZ1ITGALSMN1; SMN2
SCHEMBL6172234 0.89 IGF1R (0.47) IGF1RARPTPRZ1ITGALSMN1; SMN2
SCHEMBL6174483 0.88 IGF1R (0.42) IGF1RARITGALSMN1; SMN2KMT2A
SCHEMBL6173776 0.86 IGF1R (0.38) IGF1RARITGALRAB9ANPC1
SCHEMBL6174192 0.85 IGF1R (0.53) IGF1RITGAL
SCHEMBL6174369 0.85 IGF1R (0.45) IGF1RARITGALSMN1; SMN2KMT2A
SCHEMBL6173575 0.83 IGF1R (0.44) IGF1RARITGALSMN1; SMN2KMT2A
SCHEMBL6175060 0.82 IGF1R (0.41) IGF1RARITGALSMN1; SMN2KMT2A
SCHEMBL6174448 0.81 IGF1R (0.44) IGF1RARPTPRZ1LMNATP53
SCHEMBL6175004 0.81 IGF1R (0.42) IGF1RARITGALSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed